By Reuters
Share this articleComments
(Reuters) - Healthcare conglomerate Johnson & Johnson <JNJ.N> said on Wednesday it would buy privately held surgical robotics company Auris Health Inc for about $3.4 billion (£2.64 billion) in cash.
The agreement also includes contingent payments of $2.35 billion to Auris, J&J said.
Auris Health is a developer of robotic technologies focused on lung cancer.
(Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)
Share this articleComments